Imperial Capital Boosts Imperva (IMPV) Price Target to $55.00
Imperva (NASDAQ:IMPV) had its target price boosted by Imperial Capital from $50.00 to $55.00 in a research report sent to investors on Friday morning. The brokerage currently has an outperform rating on the software maker’s stock.
A number of other brokerages have also recently issued reports on IMPV. Evercore ISI set a $56.00 price target on shares of Imperva and gave the stock a buy rating in a research note on Friday. Morgan Stanley upped their price target on shares of Imperva from $37.00 to $39.00 and gave the stock an underweight rating in a research note on Friday. Zacks Investment Research cut shares of Imperva from a buy rating to a hold rating in a research note on Wednesday, January 10th. Piper Jaffray Companies cut shares of Imperva from an overweight rating to a neutral rating and set a $42.00 price target on the stock. in a research note on Monday, October 16th. Finally, KeyCorp reiterated a hold rating on shares of Imperva in a research note on Tuesday, October 24th. Three analysts have rated the stock with a sell rating, five have issued a hold rating and eleven have issued a buy rating to the company’s stock. Imperva has an average rating of Hold and an average target price of $52.93.
Shares of Imperva (NASDAQ:IMPV) opened at $46.55 on Friday. The firm has a market cap of $1,580.00, a PE ratio of 69.48 and a beta of 1.79. Imperva has a 1 year low of $37.17 and a 1 year high of $52.40.
Institutional investors and hedge funds have recently bought and sold shares of the business. New York State Common Retirement Fund lifted its stake in Imperva by 5.3% during the 2nd quarter. New York State Common Retirement Fund now owns 35,800 shares of the software maker’s stock valued at $1,713,000 after acquiring an additional 1,793 shares during the period. Prudential Financial Inc. increased its position in shares of Imperva by 80.7% during the 3rd quarter. Prudential Financial Inc. now owns 54,174 shares of the software maker’s stock valued at $2,351,000 after purchasing an additional 24,190 shares during the last quarter. Wells Fargo & Company MN increased its position in shares of Imperva by 11.9% during the 3rd quarter. Wells Fargo & Company MN now owns 213,953 shares of the software maker’s stock valued at $9,285,000 after purchasing an additional 22,741 shares during the last quarter. American Century Companies Inc. purchased a new stake in shares of Imperva during the 3rd quarter valued at about $6,832,000. Finally, Allianz Asset Management GmbH increased its position in shares of Imperva by 58.1% during the 3rd quarter. Allianz Asset Management GmbH now owns 59,149 shares of the software maker’s stock valued at $2,567,000 after purchasing an additional 21,732 shares during the last quarter. Institutional investors and hedge funds own 96.61% of the company’s stock.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.